Interestingly, the association between HLA-DRB1 ‘shared epitopes’ and RA risk applies to patients with antibodies directed against citrullinated proteins (ACPA), whereas the protective alleles such as DRB1*03 are associated with ACPA-negative RA [7,8]. This evidence concerns the gene PRTN3 and rheumatoid arthritis.